Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R. - Test2 - elhamkhani - TriplyDB

Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.

Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.

http://www.wikidata.org/entity/Q33780553

about

Antigenic and mutational analyses of herpes simplex virus glycoprotein B reveal four functional regions The mature virion of ectromelia virus, a pathogenic poxvirus, is capable of intrahepatic spread and can serve as a target for delayed therapy.A protein-based smallpox vaccine protects mice from vaccinia and ectromelia virus challenges when given as a prime and single boost.Vaccinia virus exhibits cell-type-dependent entry characteristics.Protection against lethal vaccinia virus challenge by using an attenuated matrix protein mutant vesicular stomatitis virus vaccine vector expressing poxvirus antigens.Global sensing of the antigenic structure of herpes simplex virus gD using high-throughput array-based SPR imaging.Repertoire of epitopes recognized by serum IgG from humans vaccinated with herpes simplex virus 2 glycoprotein D Antibody against extracellular vaccinia virus (EV) protects mice through complement and Fc receptors.Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge A protein-based smallpox vaccine protects non-human primates from a lethal monkeypox virus challenge.Antibody-induced conformational changes in herpes simplex virus glycoprotein gD reveal new targets for virus neutralization.Epitope mapping of herpes simplex virus type 2 gH/gL defines distinct antigenic sites, including some associated with biological function.Chimpanzee/human mAbs to vaccinia virus B5 protein neutralize vaccinia and smallpox viruses and protect mice against vaccinia virus.Ligand-induced and nonfusogenic dissolution of a viral membrane.Dissection of the antibody response against herpes simplex virus glycoproteins in naturally infected humans Parainfluenza virus 5-based vaccine vectors expressing vaccinia virus (VACV) antigens provide long-term protection in mice from lethal intranasal VACV challenge.Vaccinia extracellular virions enter cells by macropinocytosis and acid-activated membrane rupture.Smallpox subunit vaccine produced in Planta confers protection in mice.Major neutralizing sites on vaccinia virus glycoprotein B5 are exposed differently on variola virus ortholog B6 Adjuvant-enhanced antibody responses to recombinant proteins correlates with protection of mice and monkeys to orthopoxvirus challenges Uncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate.Vaccination with Venezuelan equine encephalitis replicons encoding cowpox virus structural proteins protects mice from intranasal cowpox virus challenge.Identification of hot spots in the variola virus complement inhibitor (SPICE) for human complement regulation.Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine.Vaccination of BALB/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge Immunity and immunological memory following smallpox vaccination.Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine.Antibody responses to vaccinia membrane proteins after smallpox vaccination.Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement Comparison of multiple vaccine vectors in a single heterologous prime-boost trial.The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.Comparative evaluation of the immune responses and protection engendered by LC16m8 and Dryvax smallpox vaccines in a mouse model.Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5.Molecular smallpox vaccine delivered by alphavirus replicons elicits protective immunity in mice and non-human primates.Serro 2 Virus Highlights the Fundamental Genomic and Biological Features of a Natural Vaccinia Virus Infecting Humans.Mechanism of neutralization of herpes simplex virus by antibodies directed at the fusion domain of glycoprotein B.Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.The interplay between Araçatuba virus and host signaling pathways: role of PI3K/Akt in viral replication.

P2860

Q24672176-F794FE02-7FB9-4FF2-BC98-7F10EEDC0A1E Q30223108-F5C278D9-1277-4B15-97BE-7BB85CD1A6C3 Q30445071-7BCE1C54-539E-493F-BF2A-451F52EB20D7 Q33698769-0E32C24F-0266-4151-96A4-32F45A27D2D3 Q33725635-B4319A96-397C-4BAA-83A7-76DE723000E0 Q33834821-6A98CD76-5C14-4094-ABBE-C21D1578E756 Q33900262-4F7E4035-45A0-48E3-85D4-5C06692908CE Q33936717-19C856B6-2FEE-4DAA-816E-859FB2F39F54 Q34092845-56A999B4-A674-45C1-A811-4C2DB2AA957A Q34126697-01883E34-2B98-4EE8-929B-14A9234F0CE0 Q34237174-22CC2064-7BA0-4B6A-B33D-84A9FD9554D1 Q34435088-EBD7F77C-F1F2-449B-9400-7C89A79BC24D Q34478724-0F8146FF-2194-43AF-A5B8-B34636DF5773 Q34507126-A61DA0AB-8A8E-418F-A2E2-19A250E8DBB9 Q34593833-D28E5C02-0FED-46C2-93B9-6D1AC4AF6475 Q35226200-672348A5-E6CC-4553-834A-64A0EDAAD7A2 Q35236032-E03493AF-14A3-4A15-A1A8-568CB6232D33 Q35800424-06C44EFF-7AE4-4E0C-9DE7-5EE280BF389F Q35947572-2CF470EF-49F2-4A63-B22F-008595AB0BB4 Q35951545-D96F0F64-454F-4C9D-A43C-26D2CF517370 Q35998125-22844180-8ACA-48C3-9DA2-0F7032EF35E6 Q36103012-BA1A2114-9599-4E02-8174-6CD4484E6A74 Q36141610-516AE393-C52A-4D96-BAB6-8AC0A664620F Q36488876-DFEDB333-7401-41A7-B4E5-757D2B44B014 Q36498115-245C2742-E86F-4310-A8D8-9BAD57796E15 Q36498147-5EB5800F-C85A-466C-8E17-DB57914124D5 Q36498244-0B9AECA6-E93F-40A6-94D9-7F24F33EDBEC Q36529039-ADBEF3D8-66D9-4D25-87F7-EFC0C922071F Q36559797-7FA47FB1-467A-42B0-9D83-6F7F4FF25267 Q36869365-4D6DFDCA-C54E-4551-AFAC-A4DAE821D026 Q37051617-D7C91493-0249-42ED-9848-E0BA77677C01 Q37107609-96859C1C-5F18-4EE9-B659-712596AFEBF7 Q37169163-EC9C0038-8788-42CE-948D-3C3657B8727E Q37349246-0C5B37E7-8A83-4B5A-B662-FA287F70FC39 Q37452067-680B5006-1B47-42EF-98F9-5B080874F857 Q37461110-A23E0BDF-96DB-47C5-96FC-2BB2182567DD Q37539293-A8ADE07E-7732-464D-A2A4-877084AA6BD2 Q37644037-7DA8AC22-509C-4381-BDD4-D98547DE2D28 Q37791160-CEDFAD59-205B-426F-8B7F-50BEDD0F6C4E Q39511373-3A165D21-B423-44E9-A49D-73348163DF14

P2860

Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.

http://www.wikidata.org/entity/Q33780553

description

2005 nî lūn-bûn

@nan

2005 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Epitope-mapping studies define ...... eloped virus glycoprotein B5R.

@ast

Epitope-mapping studies define ...... eloped virus glycoprotein B5R.

@en

type

label

Epitope-mapping studies define ...... eloped virus glycoprotein B5R.

@ast

Epitope-mapping studies define ...... eloped virus glycoprotein B5R.

@en

prefLabel

Epitope-mapping studies define ...... eloped virus glycoprotein B5R.

@ast

Epitope-mapping studies define ...... eloped virus glycoprotein B5R.

@en

P1433

Q33780553-D11AE18F-D01D-418E-9011-6CA6173069D9

P1476

Q33780553-F9758D21-2C8D-4696-BB5F-E6D4DFC2A922

P2093

Q33780553-0B166E6C-E0C4-42C3-83E1-553238D4FF63

Q33780553-43936B3D-0C6A-4D7D-B83F-F0D5DAE6B54E

Q33780553-64446E70-F034-444D-96DA-4B41B2B7807B

Q33780553-987D9C4A-BB31-4BF3-B343-C3892A7DDE9D

Q33780553-C817A30D-BF45-47E6-BC22-3FE10CC0C04E

Q33780553-E05C3DA8-4876-4D63-A951-41F548C32175

Q33780553-E114C469-6298-4B08-8512-9C60657479BB

P2860

Q33780553-0170A73C-6F16-4B68-9AE4-78E0D49050FD

Q33780553-186FE514-FAE0-4021-A1F7-60493D14616F

Q33780553-1A8C78B5-1542-476E-9AB0-F550B810775F

Q33780553-1D9AB425-6F2B-4D6F-9218-CB0242D52CB5

Q33780553-23C0DE27-70E5-40AE-8C67-2F330ED70ABE

Q33780553-2BCE7DB0-CAB1-4486-8BCB-B30DEED79E06

Q33780553-3EDADC42-4C74-4F4D-B552-73A2790FED29

Q33780553-464E22A1-8CB6-4D14-B16A-47B9AAA5DA99

Q33780553-4A5E7B17-1820-4EAA-8D91-73D83611F51A

Q33780553-4E4545D3-9509-4900-A176-A54CA44BA4CA

P304

Q33780553-19249FB0-5172-4249-8837-3C77B4FAC961

P31

Q33780553-9AF107CF-5AC0-463D-AEE8-91BFC27E09B2

P356

Q33780553-B3CC1C6B-7C1B-49A8-BD72-872BC179B6A8

P433

Q33780553-20879694-C19B-4562-999B-387097D5D36D

P478

Q33780553-54D5F4C3-C705-4265-8730-36EA6CDB3287

P50

Q33780553-2B6E78B1-DB16-4FF2-9875-F0CB0662CBEF

Q33780553-2C3D83AD-26A7-4B12-B3B9-C5B765EB8840

P577

Q33780553-3FC87906-60A4-4F5B-8212-616BCCCB47A9

P5875

Q33780553-7E5EC8CA-7931-49E1-93FD-C7BCB24AB7A5

P698

Q33780553-726EBF8B-CD97-43D5-9606-52EE31C643F1

P932

Q33780553-66E2881F-BB29-4A13-B261-B3975DAE07F1

P356

JVI.79.10.6260-6271.2005

P1433

Journal of Virology

P1476

Epitope-mapping studies define ...... eloped virus glycoprotein B5R.

@en

P2093

Gary H Cohen

http://www.w3.org/2001/XMLSchema#string

Huan Lou

http://www.w3.org/2001/XMLSchema#string

J Charles Whitbeck

http://www.w3.org/2001/XMLSchema#string

Lauren Hirao

http://www.w3.org/2001/XMLSchema#string

Lydia Aldaz-Carroll

http://www.w3.org/2001/XMLSchema#string

Manuel Ponce de Leon

http://www.w3.org/2001/XMLSchema#string

Stuart N Isaacs

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of two CD46 domains reveals an extended measles virus-binding surface

Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure.

Crystal structure of human β2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome

Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans

Structure of complement receptor 2 in complex with its C3d ligand

Folded-back solution structure of monomeric factor H of human complement by synchrotron X-ray and neutron scattering, analytical ultracentrifugation and constrained molecular modelling

The crystal structure of human CD21: Implications for Epstein-Barr virus and C3d binding.

Mapping CD55 function. The structure of two pathogen-binding domains at 1.7 A

The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution

Multipin peptide libraries for antibody and receptor epitope screening and characterization.

P304

6260-6271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.79.10.6260-6271.2005

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

79

http://www.w3.org/2001/XMLSchema#string

P50

Roselyn J. Eisenberg

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7880103

http://www.w3.org/2001/XMLSchema#string

P698

15858010

http://www.w3.org/2001/XMLSchema#string

P932

1091701

http://www.w3.org/2001/XMLSchema#string